TCI Wealth Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

TCI Wealth Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,262	Closed	-$16K	–	2410
2023 Q1	$16K	Buy	6,262 +100	+2%	+$206	﹤0.01%	822
2022 Q4	$9.18K	Hold	6,162	–	–	﹤0.01%	1133
2022 Q3	$11K	Hold	6,162	–	–	﹤0.01%	981
2022 Q2	$8K	Hold	6,162	–	–	﹤0.01%	1199
2022 Q1	$14K	Hold	6,162	–	–	﹤0.01%	904
2021 Q4	$28K	Buy	6,162 +200	+3%	+$661	﹤0.01%	572
2021 Q3	$48K	Hold	5,962	–	–	0.01%	438
2021 Q2	$59K	Hold	5,962	–	–	0.01%	363
2021 Q1	$53K	Hold	5,962	–	–	0.02%	342
2020 Q4	$61K	Hold	5,962	–	–	0.03%	304
2020 Q3	$54K	Hold	5,962	–	–	0.02%	301
2020 Q2	$43K	Buy	+5,962	New	+$63.3K	0.02%	333

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

TCI Wealth Advisors's GRTX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2023, closing a stake of 6,262 shares — an estimated $16K sold.

TCI Wealth Advisors first reported a position in GRTX in Q2 2020 and held it in 12 quarters. The position peaked at $61K in Q4 2020. 55 funds tracked by Wall St. Rank hold GRTX as of Q2 2023.

TCI Wealth Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 6,262 Galera Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $16K.
TCI Wealth Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
TCI Wealth Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $61K in Q4 2020.
55 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.